Phio Pharmaceuticals PHIO
NASDAQ PHIO
$0.87 -0.03 (-3.71%)
As of: Oct 22, 2026 · 3:59 PM EDT

Phio Pharmaceuticals (PHIO) Deferred Taxes (2017)

Updated

Phio Pharmaceuticals' Deferred Taxes was -$1.62 million in FY2017.

Analysis

Phio Pharmaceuticals (PHIO) Deferred Taxes (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -1.79 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -195.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -587.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -1.32 Bn
10 Phio Pharmaceuticals 10.13 Mn -51.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 -1.62 Mn
API Access

Phio Pharmaceuticals Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=PHIO&period=max&api_key=YOUR_API_KEY